Manhattan Bridge Capital - LOAN Stock Forecast, Price & News

Manhattan Bridge Capital's stock was trading at $5.33 at the start of the year. Since then, LOAN shares have increased by 6.8% and is now trading at $5.69.
View the best growth stocks for 2023 here.

Manhattan Bridge Capital saw a decrease in short interest during the month of January. As of January 15th, there was short interest totaling 18,200 shares, a decrease of 42.4% from the December 31st total of 31,600 shares. Based on an average trading volume of 16,300 shares, the days-to-cover ratio is currently 1.1 days. Approximately 0.2% of the shares of the company are short sold.
View Manhattan Bridge Capital's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, March 10th 2023.
View our LOAN earnings forecast.

Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) posted its quarterly earnings data on Friday, March, 11th. The credit services provider reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.10 by $0.01. Manhattan Bridge Capital had a trailing twelve-month return on equity of 11.94% and a net margin of 63.98%.

Manhattan Bridge Capital declared a quarterly dividend on Friday, December 9th. Investors of record on Friday, December 30th will be given a dividend of $0.125 per share on Tuesday, January 17th. This represents a $0.50 annualized dividend and a dividend yield of 8.79%. The ex-dividend date of this dividend is Thursday, December 29th.
Read our dividend analysis for LOAN.

Manhattan Bridge Capital (NASDAQ:LOAN) pays an annual dividend of $0.50 per share and currently has a dividend yield of 8.62%. LOAN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 111.11%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for LOAN.

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Bridge Capital investors own include Allena Pharmaceuticals (ALNA), Energy Transfer (ET), AcelRx Pharmaceuticals (ACRX), Actinium Pharmaceuticals (ATNM), B&G Foods (BGS), Enterprise Products Partners (EPD), Global Medical REIT (GMRE), Kimco Realty (KIM), Mylan (MYL) and Rigel Pharmaceuticals (RIGL).

Manhattan Bridge Capital trades on the NASDAQ under the ticker symbol "LOAN."

Manhattan Bridge Capital's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Shufro Rose & Co. LLC (1.72%), Clear Creek Financial Management LLC (0.39%), Fi3 FINANCIAL ADVISORS LLC (0.33%), Bank of Montreal Can (0.19%), International Assets Investment Management LLC (0.16%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Assaf Ran, Lyron L Bentovim, Michael Jackson and Vanessa Kao.
View institutional ownership trends.

Shares of LOAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LOAN stock can currently be purchased for approximately $5.69.

Manhattan Bridge Capital (NASDAQ:LOAN) has a market capitalization of $65.38 million and generates $6.81 million in revenue each year. The credit services provider earns $4.42 million in net income (profit) each year or $0.45 on an earnings per share basis.

Manhattan Bridge Capital's mailing address is 60 CUTTER MILL RD. SUITE 205, GREAT NECK NY, 11021. The official website for the company is www.manhattanbridgecapital.com. The credit services provider can be reached via phone at (516) 444-3400 or via fax at 516-444-3404.